Brief: Kaken Pharmaceutical signs agreement with Dong-A ST for Clenafin/Jublia in Korea31/05/2016 04:03
Brief: Tobira Therapeutics and DONG-A ST enter into license agreements for evogliptin and cenicriviroc11/04/2016 12:58
Last trade - 00:00